The CRL comes after the FDA accepted the NDA for review in October 2025 and set a Prescription Drug User Fee Act target ...

The authors describe Medicare Advantage plans that screen for and provide supplemental benefits addressing social needs and ...

James F. Howard, MD, discusses what he believes will be the next steps in treating myasthenia gravis. CAR-T therapies could ...

Real-world data suggest nirogacestat boosts response in desmoid tumor vs standard-of-care treatment, but small cohorts leave ...

The Medicare GLP-1 Bridge's July 1 launch is now the only concrete milestone on the calendar. Whether it becomes the ...

Many rural providers, like critical access hospitals, rely on cost-based reimbursement or flat, encounter-based payments like ...

Early detection of chronic kidney disease (CKD) means little if it does not lead to timely treatment, yet a significant gap ...

As obesity rates continue to climb in the US, clinicians across specialties are confronting the reality that although ...

Community oncology practices face major infrastructure and reimbursement gaps when delivering bispecific antibodies. Beyond ...

New CMS Medicaid work requirements could increase employment but may also cause millions of adults to lose coverage by 2027.

In part 2 of her interview with The American Journal of Managed Care®, Meng-Han Tsai, PhD, assistant professor at Augusta ...

Clinicians gathered in Houston, Texas, to examine how newer drug options are reshaping cardiometabolic care and how ...